Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Urology and Nephrology
Literature
1.
Solak Y, Gul EE, Kayrak M, Atalay H, Abdulhalikov T, Turk S, Covic A, Kanbay M (2013) Electrocardiographic P-wave characteristics in patients with end-stage renal disease: P-index and interatrial block. Int Urol Nephrol 2:511–517CrossRef
2.
3.
Bayés de Luna A, Platonov P, Cosio FG, Cygankiewicz I, Pastore C, Baranowski R, Bayés-Genis A, Guindo J, Viñolas X, Garcia-Niebla J, Barbosa R, Stern S, Spodick D (2012) Interatrial blocks. A separate entity from left atrial enlargement: a consensus report. J Electrocardiol 45(5):445–451CrossRefPubMed
4.
Ariyarajah V, Asad N, Tandar A, Spodick DH (2005) Interatrial block: pandemic prevalence, significance, and diagnosis. Chest 128(2):970–975CrossRefPubMed
5.
Enriquez A, Conde D, Redfearn DP, Baranchuk A (2014) Progressive interatrial block and supraventricular arrhythmias. Ann Noninvasive Electrocardiol. doi:10.​1111/​anec.​12208
6.
Chhabra L, Devadoss R, Chaubey VK, Spodick DH (2014) Interatrial block in the modern era. Curr Cardiol Rev 10(3):181–189CrossRefPubMed
7.
Marano M, D’Amato A, Bayés de Luna A, Baranchuk A (2014) Hemodialysis affects interatrial conduction. Ann Noninvasive Electrocardiol 2(3):154
Metadata
Title
Prevalence and determinants of interatrial block in hemodialysis patients
Authors
Marco Marano
Anna D’Amato
Giuseppe Tomasino
Francesco Izzo
Marco Capasso
Eugenio Auletta
Publication date
01-03-2015
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 3/2015
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-015-0914-3

Other articles of this Issue 3/2015

International Urology and Nephrology 3/2015 Go to the issue

Nephrology - Review

Osteoporosis after renal transplantation

Nephrology – Original Paper

Efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in patients with chronic kidney disease: a systematic review and meta-analysis

Urology - Original Paper

Bicalutamide 150 mg as secondary hormonal therapy for castration-resistant prostate cancer

Nephrology - Original Paper

The effects of short-term vitamin D supplementation on glucose metabolism in dialysis patients: a systematic review and meta-analysis

Urology - Original Paper

Intradetrusor injection of adult muscle-derived cells for the treatment of underactive bladder: pilot study

Urology – Letter to the Editor

Laparoscopic retroperitoneal radical nephrectomy in a pregnant woman with retrocaval artery
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits